<?xml version='1.0' encoding='utf-8'?>
<ns0:urlset xmlns:ns0="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:ns1="http://www.google.com/schemas/sitemap-news/0.9">
  <ns0:url><ns0:loc>https://enclai.net/news/whooping-cough-pertussis-aus-2026-11-16</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T22:30:55+00:00</ns1:publication_date><ns1:title>Whooping cough in Australia: 2,795 cases in 90 days</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/seasonal-influenza-can-2026-11-15</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T14:31:31+00:00</ns1:publication_date><ns1:title>53% fewer flu cases in Canada: 3,146 in the last 30 days</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/hepatitis-a-ven-2026-11-15</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T12:31:08+00:00</ns1:publication_date><ns1:title>28% fewer hepatitis a cases in Venezuela: 34 in the last 30 days</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/study-43013837-intismeran-autogene-plus-pembrolizumab-for-resected-stage-iib-to-iv-melanoma</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T11:49:57+00:00</ns1:publication_date><ns1:title>Intismeran plus pembrolizumab improves recurrence-free survival in resected stage IIB to IV melanoma</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/sec-nektar-therapeutics-uk-limited-0001193125-26-458868-2026-11-13</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T09:55:16+00:00</ns1:publication_date><ns1:title>Nektar Therapeutics UK: $9.4M revenue, $44.1M R&amp;D, quarter to Sep 2026</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/sec-cumberland-0001087294-26-000079-2026-11-13</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T09:55:16+00:00</ns1:publication_date><ns1:title>Cumberland: $2.2M revenue, $841,162 R&amp;D, quarter to Sep 2026</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/sec-journey-medical-corp-0001104659-26-126285-2026-11-12</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T09:55:16+00:00</ns1:publication_date><ns1:title>Journey Medical: $19.0M revenue, $51,000 R&amp;D, quarter to Sep 2026</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/sec-macrogenics-inc-0001125345-26-000073-2026-11-12</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T09:55:16+00:00</ns1:publication_date><ns1:title>Macrogenics: $18.7M revenue, $30.6M R&amp;D, quarter to Sep 2026</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/measles-gha-2026-11-15</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T08:32:44+00:00</ns1:publication_date><ns1:title>Measles in Ghana: 63 suspected cases in records dated 13 September</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/campylobacteriosis-deu-2026-11-15</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T08:31:50+00:00</ns1:publication_date><ns1:title>Campylobacteriosis in Germany: 7,885 cases in 90 days</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/cholera-yem-2026-11-15</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T05:31:02+00:00</ns1:publication_date><ns1:title>Cholera in Yemen: 4,117 cases in 90 days, 418 in the last 30</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/dengue-fever-mys-2026-11-15</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-15T01:31:12+00:00</ns1:publication_date><ns1:title>Dengue in Malaysia: 22,651 cases in 90 days, 6,286 in the last 30</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/campylobacteriosis-aus-2026-11-15</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-14T22:30:37+00:00</ns1:publication_date><ns1:title>Campylobacteriosis in Australia: 8,531 cases in 90 days</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/dengue-fever-usa-2026-11-14</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-14T14:31:38+00:00</ns1:publication_date><ns1:title>60% more dengue cases in the US: 936 in the last 30 days</ns1:title></ns1:news></ns0:url>
  <ns0:url><ns0:loc>https://enclai.net/news/chikungunya-fever-bra-2026-11-14</ns0:loc><ns1:news><ns1:publication><ns1:name>ENCLAI AlertX</ns1:name><ns1:language>en</ns1:language></ns1:publication><ns1:publication_date>2026-11-14T13:01:49+00:00</ns1:publication_date><ns1:title>76% fewer chikungunya cases in Brazil: 387 in the last 30 days</ns1:title></ns1:news></ns0:url>
</ns0:urlset>